HIV protease inhibitors with picomolar potency against PI-Resistant HIV-1 by extension of the P3 substituent-Reference-Cited by-同舟云学术

HIV protease inhibitors with picomolar potency against PI-Resistant HIV-1 by extension of the P3 substituent

Published:2003-08 Issue:15 Volume:13 Page:2569-2572
ISSN:0960-894X
Container-title:Bioorganic & Medicinal Chemistry Letters
language:en
Short-container-title:Bioorganic & Medicinal Chemistry Letters

Author:

Duffy Joseph L.,Rano Thomas A.,Kevin Nancy J.,Chapman Kevin T.,Schleif William A.,Olsen David B.,Stahlhut Mark,Rutkowski Carrie A.,Kuo Lawrence C.,Jin Lixia,Lin Jiunn H.,Emini Emilio A.,Tata James R.

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference16 articles.

1. Kempf, D. J.; Molla, A.; Hsu, A. In Antiretroviral Therapy; De Clercq, E. Ed.; ASM: Washington D. C., 2001; pp 147–174.

2. Development and significance of resistance to protease inhibitors in HIV-1-infected adults under triple-drug therapy in clinical practice

3. Identification of MK-944a: A Second Clinical Candidate from the Hydroxylaminepentanamide Isostere Series of HIV Protease Inhibitors

4. HIV-1 protease inhibitors in development

5. Synthesis and activity of novel HIV protease inhibitors with improved potency against multiple PI-resistant viral strains

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An Efficient Synthesis of a Hydroxyethylamine (HEA) Isostere and Its α-Aminophosphonate and Phosphoramidate Derivatives as Potential Anti-HIV Agents;ChemMedChem;2012-07-11

2. Synthesis of 3,3-disubstituted oxetane building blocks;Tetrahedron Letters;2011-02

3. Synthesis of Novel Angular Spirocyclic Azetidines;Organic Letters;2011-01-14

4. Oxetanes as Versatile Elements in Drug Discovery and Synthesis;Angewandte Chemie International Edition;2010-10-28

5. Oxetane als vielseitige Bausteine in der Wirkstoff-Forschung und Synthese;Angewandte Chemie;2010-10-28